Related Experiment Video
Updated: Aug 18, 2025

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases
Alexander V Blagov1, Sergey Kozlov2, Tatiana Blokhina2
1Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia.
Insights
Mitochondrial dynamics disorders are implicated in cardiovascular diseases. Targeting proteins involved in mitochondrial fission, fusion, and mitophagy offers a promising therapeutic strategy for developing new cardiac drugs.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Drug Development
Background:
- Cardiovascular diseases (CVDs) represent a major global health burden.
- Identifying novel therapeutic targets is crucial for advancing CVD treatment.
- Mitochondrial dysfunction is increasingly recognized in the pathogenesis of cardiac conditions.
Purpose of the Study:
- To review the role of mitochondrial dynamics in cardiovascular diseases.
- To explore therapeutic targeting of mitochondrial dynamics proteins for cardiac drug development.
- To analyze the potential of specific protein targets in existing drug development pipelines.
Main Methods:
- Literature review focusing on mitochondrial dynamics processes (fission, fusion, mitophagy, transport, biogenesis).
- Analysis of pathogenetic mechanisms linking mitochondrial dynamics to cardiomyocyte dysfunction.
- Examination of current drug development strategies targeting mitochondrial proteins.
Main Results:
- Disruptions in mitochondrial fission and fusion are associated with pathological cardiac states.
- Impaired mitophagy contributes to the progression of cardiovascular diseases.
- Mitochondrial transport and biogenesis alterations are critical in cardiomyocyte health.
Conclusions:
- Therapeutic strategies targeting mitochondrial dynamics proteins show promise for novel cardiovascular drug development.
- Understanding the intricate processes of mitochondrial dynamics is key to combating cardiovascular diseases.
- Further research into these protein targets could lead to innovative cardiac therapies.
Abstract:
Cardiovascular diseases are one of the leading causes of death worldwide. The identification of new pathogenetic targets contributes to more efficient development of new types of drugs for the treatment of cardiovascular diseases. This review highlights the problem of mitochondrial dynamics disorders, in the context of cardiovascular diseases. A change in the normal function of mitochondrial dynamics proteins is one of the reasons for the development of the pathological state of cardiomyocytes. Based on this, therapeutic targeting of these proteins may be a promising strategy in the development of cardiac drugs. Here we will consider changes for each process of mitochondrial dynamics in cardiovascular diseases: fission and fusion of mitochondria, mitophagy, mitochondrial transport and biogenesis, and also analyze the prospects of the considered protein targets based on existing drug developments.
More Related Videos
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Mitochondrial Precursor Proteins
Most of the mitochondrial...
ATP Synthase: Mechanism
The Inner Mitochondrial Membrane
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...